These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1509713)
1. [Hyperinsulinism as a major etiopathogenic link with arterial hypertension, hyperlipoproteinemia and hirsutism. II]. Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J Vnitr Lek; 1992 May; 38(5):438-47. PubMed ID: 1509713 [TBL] [Abstract][Full Text] [Related]
2. [Clinical manifestations of insulin resistance. The hormonal-metabolic syndrome X (5H), its prevalence and impact on cardiovascular morbidity and mortality. I]. Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J Vnitr Lek; 1992 May; 38(5):426-37. PubMed ID: 1509712 [TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance and arterial hypertension. Hyperinsulinism as a basic etiopathogenic factor in essential arterial hypertension and associated phenomena]. Hrnciar J; Hrnciarová M; Jakubíková K; Korónyi S Vnitr Lek; 1992 Sep; 38(9):868-78. PubMed ID: 1481385 [TBL] [Abstract][Full Text] [Related]
4. [Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis]. Hrnciar J Vnitr Lek; 1995 Feb; 41(2):92-8. PubMed ID: 7725646 [TBL] [Abstract][Full Text] [Related]
5. [Hyperinsulinism and the coronary syndrome]. Hrnciar J Vnitr Lek; 1992 Nov; 38(11):1056-65. PubMed ID: 1494868 [TBL] [Abstract][Full Text] [Related]
6. [How should we implement the basic principles of treatment of type 2 diabetes mellitus from the aspect of the hormono-metabolic syndrome X (5H)?]. Hrnciar J; Jakubíková K; Okapcová J Vnitr Lek; 1992 Aug; 38(8):729-37. PubMed ID: 1455753 [TBL] [Abstract][Full Text] [Related]
7. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome]. Hrnciar J Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027 [TBL] [Abstract][Full Text] [Related]
9. [Relation between levels of leptin, insulin and cortisol in persons with the 5H (X) syndrome]. Hrnciar J; Okapcová J; Lepej J; Gábor D Vnitr Lek; 1998 Feb; 44(2):68-75. PubMed ID: 9820079 [TBL] [Abstract][Full Text] [Related]
10. [Hyperinsulinism--a new pathogenic cause of cardiovascular diseases]. Kúseková M; Sasinka M Cesk Pediatr; 1993 Mar; 48(3):136-40. PubMed ID: 8495516 [TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian syndrome: the next cardiovascular dilemma in women? Srikanthan P; Korenman S; Davis S Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589 [TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and the polycystic ovary syndrome. Pelusi B; Gambineri A; Pasquali R Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409 [TBL] [Abstract][Full Text] [Related]
15. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476 [TBL] [Abstract][Full Text] [Related]
16. Type II diabetes and syndrome X. Pathogenesis and glycemic management. Karam JH Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069 [TBL] [Abstract][Full Text] [Related]
17. [Hypertension and hyperinsulinism in non-insulin-dependent diabetes. A study of 230 patients]. Billault B; Schweich H; Daurelle P; Passa P Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1169-72. PubMed ID: 8129522 [TBL] [Abstract][Full Text] [Related]
18. [The value of certain parameters in the diagnosis and detection of metabolic X syndrome]. Suba I; Halmos T; Kautzky L Orv Hetil; 1997 Sep; 138(38):2407-11. PubMed ID: 9380379 [TBL] [Abstract][Full Text] [Related]
19. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome. Tan TT; Lui SK; Satgunasingam N; Khalid BA Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038 [TBL] [Abstract][Full Text] [Related]